Table 3.
Factors | LTFU cases/patients, (%) | OR | 95% CI | P value | aOR† | 95% CI | P value |
Sex (n = 3,953): | |||||||
Male | 430/1,332 (32.3) | 1.0 | 1.0 | ||||
Female | 731/2,621 (27.9) | 0.81 | 0.70 to 0.94 | 0.004 | 0.79 | 0.67 to 0.93 | 0.005 |
Age, years (n = 3952): | |||||||
≥39 | 118/384 (30.7) | 1.0 | 1.0 | ||||
40 to 49 | 242/1,056 (22.9) | 0.67 | 0.52 to 0.87 | 0.003 | 0.72 | 0.54 to 0.98 | 0.034 |
50 to 59 | 389/1,395 (27.9) | 0.87 | 0.68 to 1.11 | 0.27 | 1.02 | 0.77 to 1.36 | 0.878 |
≥60 | 412/1,117 (36.9) | 1.32 | 1.02 to 1.69 | 0.03 | 1.54 | 1.15 to 2.05 | 0.004 |
Type of diabetes (n = 3953): |
|||||||
Type 1 | 20/42 (47.6) | 1.0 | 1.0 | ||||
Type 2 | 1,141/3,911 (29.2) | 0.45 | 0.25 to 0.83 | 0.01 | 0.50 | 0.25 to 1.01 | 0.053 |
Origin (n = 3952): | |||||||
District of clinic | 460/1,641 (28.0) | 1.0 | 1.0 | ||||
Other districts | 391/1,473 (26.5) | 0.93 | 0.79 to 1.09 | 0.35 | 1.01 | 0.84 to 1.21 | 0.88 |
Outside province | 310/838 (37.0) | 1.51 | 1.26 to 1.80 | <0.001 | 1.68 | 1.38 to 2.06 | <0.001 |
Last BMI, kg/m2, (n = 3901): | |||||||
<23.0 | 581/1,708 (34.0) | 1.0 | 1.0 | ||||
≥23.0 | 547/2,193 (24.9) | 0.64 | 0.56 to 0.74 | <0.001 | 0.70 | 0.60 to 0.82 | <0.001 |
Last RBG, mg/dl (n = 3659): | |||||||
<180 | 330/1,688 (19.6) | 1.0 | 1.0 | ||||
≥180 | 621/1,971 (31.5) | 1.89 | 1.62 to 2.21 | <0.001 | 1.81 | 1.54 to 2.13 | <0.001 |
Last consultation (n = 3927): | |||||||
Not late | 686/2,960 (23.2) | 1.0 | 1.0 | ||||
Late | 474/967 (49.0) | 3.19 | 2.74 to 3.71 | <0.001 | 2.72 | 2.29 to 3.24 | <0.001 |
*Included are all patients who initiated treatment between March 2002 and February 2008 and who attended at least two consultations.
†All factors with P value < 0.05 in univariate analysis were included in the multivariable regression model. P value for the likelihood ratio test for the model was <0.001.
aOR = adjusted odds ratio; BMI = body mass index; CI = confidence interval; OR = odds ratio; RBG = random blood glucose.